These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3906604

  • 1. [Effect of pindolol (Visken) on plasma and blood volume in men with primary arterial hypertension].
    Wyrzykowski B, Suchecka-Rachoń K.
    Pol Tyg Lek; 1985 Sep 23; 40(38):1083-6. PubMed ID: 3906604
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of combined use of pindolol and clopamide on arterial blood pressure and blood and plasma volume in patients with primary arterial hypertension].
    Wyrzykowski B, Suchecka-Rachoń K.
    Pol Arch Med Wewn; 1987 Sep 23; 77(1-2):25-30. PubMed ID: 3079499
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of pindolol treatment on left-ventricular systolic and diastolic time intervals in men with borderline primary arterial hypertension].
    Gross-Sawicka E, Wyrzykowski B, Krupa-Wojciechowska B.
    Pol Tyg Lek; 1988 Jul 04; 43(27):880-4. PubMed ID: 3072537
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of treatment with pindolol (Visken) on hemodynamics in patients with primary hypertension].
    Wyrzykowski B, Suchecka-Rachoń K.
    Kardiol Pol; 1986 Jul 04; 29(4):285-91. PubMed ID: 3537436
    [No Abstract] [Full Text] [Related]

  • 5. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I.
    Adv Clin Pharmacol; 1976 Jul 04; 11():1114-8. PubMed ID: 802071
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel, Gyntelberg F.
    Ugeskr Laeger; 1973 May 17; 135(20):971-4. PubMed ID: 4585570
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM, Freire CA.
    Arq Bras Cardiol; 1981 Sep 17; 37(3):219-24. PubMed ID: 7052028
    [No Abstract] [Full Text] [Related]

  • 8. [Prolonged antihypertensive effect of beta-adrenolytic treatment with Visken in patients with essential hypertension].
    Lukasik S, Halawa B, Surowiak M, Kasprzak J.
    Pol Tyg Lek; 1977 Nov 21; 32(47):1837-9. PubMed ID: 341096
    [No Abstract] [Full Text] [Related]

  • 9. [Controlled study of high blood pressure treatment using betablocker Visken (author's transl)].
    Ripka O, Linhartová J, Jarolím M, Okrouhlík B, Chvatíková J.
    Sb Lek; 1975 Oct 21; 77(10):294-7. PubMed ID: 1101360
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical use of pindolol (Visken) in the treatment of arterial hypertension].
    Lambić IS, Krstić Lj.
    Srp Arh Celok Lek; 1977 Feb 21; 105(2):191-200. PubMed ID: 905885
    [No Abstract] [Full Text] [Related]

  • 11. [Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
    Khomenko VL, Vasiuk IuA, Romashkin AV, Sivkov SI, Mel'nikov AIu, Buskin VD.
    Sov Med; 1990 Feb 21; (3):64-7. PubMed ID: 2195673
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Pindolol in arterial hypertension. A double-blind study (author's transl)].
    Basso B, Roman O.
    Rev Med Chil; 1976 Mar 21; 104(3):143-7. PubMed ID: 781772
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.